Rt. Hon. Don Mazankowski
Chairman of the Board |
Dr. Michael Hayden
Scientific Director
Canadian Genetic Diseases Network |
Dr. Eniko Megyeri-Lawless
Networks of Centres of Excellence Program |
Mr. Rob Abbott
President
Abbott Strategies |
Dr. Robert Heft
VP Product Development
BioMarin Pharmaceuticals |
Mr. Maurice Mourton |
Mr. David Arkowitz
Controller
Merck & Co. |
Dr. Tom Hudson
Associate Scientific Director
Canadian Genetic Diseases Network |
Dr. Heather Munroe-Blum
Vice President of Research
University of Toronto |
Mr. Jean-Michel Halfon
President & CEO Officer
Pfizer Canada Inc. |
Mr. Louis Lacasse
President
GeneChem Technologies
Venture Fund Laval |
Dr. Martha Piper
President
University of British Columbia |
Mr. Noel Hall
President
Aspreva Pharmaceuticals |
Dr. Lap-Chee Tsui
Associate Scientific Director
Canadian Genetic Diseases Network |
Dr. Ron Woznow
Chief Executive Officer
Canadian Genetic Diseases Network |
